-
Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States
Mar 10, 2025, 14:00 PM -
Cost Effectiveness Analysis of Lanadelumab vs C1 Inhibitor for Long-Term Prophylaxis of Hereditary Angioedema: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective
Mar 10, 2025, 14:00 PM -
Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization
Mar 10, 2025, 14:00 PM -
A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens
Mar 10, 2025, 14:00 PM -
Wider Societal Impact of Reducing Prevalence of Obesity: A Comparison of US and UK Impact Frameworks
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Screening for Cervical Lesion and Diagnosis and Treatment of Cervical Cancer In Nigeria
Mar 10, 2025, 14:00 PM -
Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea
Mar 10, 2025, 14:00 PM -
Real-World Economic and Clinical Burden of Worsening Heart Failure in the US: Administrative Claims Database Analysis
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics
Mar 10, 2025, 14:00 PM -
Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients With Fragile X Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec
Mar 10, 2025, 14:00 PM -
Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data
Mar 10, 2025, 14:00 PM -
Temporal Trends in Healthcare Costs Associated with First-Line (1L) Nivolumab + Ipilimumab (N+I) and Pembrolizumab + Lenvatinib (P+L) in Advanced or Metastatic Renal Cell Carcinoma (aRCC)
Mar 10, 2025, 14:00 PM -
Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey
Mar 10, 2025, 14:00 PM
